Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy

Capuron, L, Ravaud, A, Neveu, P J, Miller, A H, Maes, M, Dantzer, R·2002·Molecular Psychiatry

Cited by (471)

Items 101–200 of 471

  1. TNFα mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress
    Yuning Liu, Yunli Peng, Lei Liu, Teng‐Yun Wu, Yi Zhang, Yong‐Jie Lian, Yuanyuan Yang, Keith W. Kelley, Chun‐Lei Jiang, Yunxia Wang · 2015 · European Cytokine Network
  2. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Michael H. J. Maes, Ivanka Mihaylova, Marcel De Ruyter, Marta Kubera, Eugène Bosmans · 2007 · PubMed
  3. The role of neuroinflammation on pathogenesis of affective disorders
    Rhie, Sung Ja, Jung, Eun-Yee, Shim, Insop · 2020 · Journal of Exercise Rehabilitation
  4. Curcumin relieves depressive-like behaviors via inhibition of the NLRP3 inflammasome and kynurenine pathway in rats suffering from chronic unpredictable mild stress
    Wenyuan Zhang, Yujin Guo, Wenxiu Han, Mengqi Yang, Luping Wen, Keyi Wang, Pei Jiang · 2018 · International Immunopharmacology
  5. Tryptophan Switch for a Photoactivated Platinum Anticancer Complex
    Jennifer S. Butler, Julie A. Woods, Nicola J. Farrer, Mark E. Newton, Peter John Sadler · 2012 · Journal of the American Chemical Society
  6. Successful Antidepressant Therapy Restores the Disturbed Interplay Between TNF-α System and HPA Axis
    Hubertus Himmerich, Elisabeth B. Binder, Heike E. Kunzel, Andreas Schuld, Susanne Lucae, Manfred Uhr, Thomas Pollmächer, Florian Holsboer, Marcus Ising · 2006 · Biological Psychiatry
  7. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1β and tumor necrosis factor-α
    Jennifer M. Loftis, Marilyn S. Huckans, Samantha Ruimy, David J. Hinrichs, Péter Hauser · 2007 · Neuroscience Letters
  8. Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
    Carolina Hoyo-Becerra, JF Schlaak, Dirk Matthias Hermann · 2014 · Brain Behavior and Immunity
  9. The possible role of the kynurenine pathway in adolescent depression with melancholic features
    Vilma Gabbay, RACHEL GITTELMAN KLEIN, Yisrael Katz, Sandra Mendoza, Leah E. Guttman, Carmen M. Alonso, James S. Babb, Glenn S. Hirsch, Leonard Liebes · 2010 · Journal of Child Psychology and Psychiatry
  10. Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory
    Jillian M. Heisler, Jason C. O’Connor · 2015 · Brain Behavior and Immunity
  11. Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder
    Andreas Baranyi, Omid Amouzadeh-Ghadikolai, Dirk von Lewinski, Hans‐Bernd Rothenhäusler, Simon Theokas, Christoph Robier, Harald Mangge, G Reicht, Peter Hlade, Andreas Meinitzer · 2016 · PLoS ONE
  12. Peripheral and cerebral metabolic abnormalities of the tryptophan–kynurenine pathway in a murine model of major depression
    Anthony Laugeray, Jean‐Marie Launay, Jacques Callebert, Alexandre Surget, Catherine Belzung, Pascal R. Barone · 2010 · Behavioural Brain Research
  13. Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling
    Geoffroy O. Laumet, Jules D. Edralin, Angie C.A. Chiang, Robert Dantzer, Cobi J. Heijnen, Annemieke Kavelaars · 2018 · Neuropsychopharmacology
  14. Tryptophan, mood, and cognitive function
    Wim J. Riedel, Tineke Klaassen, Jeroen A. J. Schmitt · 2002 · Brain Behavior and Immunity
  15. Depression, cytokines, and pancreatic cancer
    Breitbart, William, Rosenfeld, Barry, Tobias, Kristen, Pessin, Hayley, Ku, Geoffrey Y., Yuan, Jianda, Wolchok, Jedd · 2014 · Psycho-Oncology
  16. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway
    Bo Wang, Yong‐Jie Lian, Wenjun Su, Peng Wei, Xin Wen Dong, Lin-Lin Liu, Hong Gong, Ting Zhang, Chun‐Lei Jiang, Yunxia Wang · 2017 · Brain Behavior and Immunity
  17. Mechanisms of Inflammation-Associated Depression: Immune Influences on Tryptophan and Phenylalanine Metabolisms
    Barbara Strasser, Barbara Sperner‐Unterweger, Dietmar Fuchs, Johanna Maria Gostner · 2016 · Current topics in behavioral neurosciences
  18. Bacille Calmette‐Guérin Inoculation Induces Chronic Activation of Peripheral and Brain Indoleamine 2,3‐Dioxygenase in Mice
    Maïté Marie Moreau, Jacques Lestage, Danièle Verrier, Cécile Mormède, Keith W. Kelley, Robert Dantzer, Nathalie Castanon · 2005 · The Journal of Infectious Diseases
  19. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation
    Martina M. Hughes, Angela Carballedo, Declan M. McLoughlin, Francesco Amico, Andrew Harkin, Thomas Frodl, Thomas J. Connor · 2012 · Brain Behavior and Immunity
  20. The role of the cytokine network in psychological stress
    Yong‐Ku Kim, Michael H. J. Maes · 2003 · Acta Neuropsychiatrica
  21. Biomarkers of post-covid depression
    Lorkiewicz, Piotr, Waszkiewicz, Napoleon · 2021 · Journal of Clinical Medicine
  22. Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour
    Sinead M. Gibney, Eimear M. Fagan, Ann‐Marie Waldron, Jordan O’Byrne, Thomas J. Connor, Andrew Harkin · 2014 · The International Journal of Neuropsychopharmacology
  23. The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus
    Nan Wang, Haiying Yu, Xiaofeng Shen, Zhiqin Gao, Chun Yang, Jianjun Yang, Guang-Fen Zhang · 2015 · Upsala Journal of Medical Sciences
  24. Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application
    Watkins, C C, Sawa, A, Pomper, M G · 2014 · Translational Psychiatry
  25. Co-occurring Hepatitis C, Substance Use, and Psychiatric Illness: Treatment Issues and Developing Integrated Models of Care
    Diana L. Sylvestre · 2004 · Journal of Heredity
  26. Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression
    Sudan Prasad Neupane · 2016 · Frontiers in Immunology
  27. Are medical comorbid conditions of bipolar disorder due to immune dysfunction?
    Joshua Daniel Rosenblat, Roger S. McIntyre · 2015 · Acta Psychiatrica Scandinavica
  28. Psychiatric side effects of interferon-β in multiple sclerosis
    Jean-Louis Goëb, CHRISTIAN EVEN, Guillaume Nicolas, Bénédicte Gohier, F. Dubas, J.-B. Garré · 2005 · European Psychiatry
  29. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy
    Maria Pertl, David Hevey, Noreen T. Boyle, Martina M. Hughes, Sonya Collier, Anne-Marie O’Dwyer, Andrew Harkin, M. John Kennedy, Thomas J. Connor · 2013 · Brain Behavior and Immunity
  30. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery
    Matthew James Robson, Meagan A. Quinlan, Randy Blakely · 2017 · ACS Chemical Neuroscience
  31. Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
    Jonathan B. Savitz · 2016 · Current topics in behavioral neurosciences
  32. Chronic psychosocial stress down-regulates central cytokines mRNA
    Alessandro Bartolomucci, Paola Palanza, Stefano Parmigiani, Tiziana Pederzani, Élodie Merlot, Pierre J. Neveu, Robert Dantzer · 2003 · Brain Research Bulletin
  33. Central nervous system inflammation in disease related conditions: Mechanistic prospects
    Anthony Fung, Marcela Paola Vizcaychipi, Dafydd G. Lloyd, Yanjie Wan, Daqing Ma · 2012 · Brain Research
  34. Serum kynurenic acid is reduced in affective psychosis
    Brent E. Wurfel, Wayne Curtis Drevets, S A Bliss, J R McMillin, Hideo Suzuki, Bart N. Ford, Harvey M. Morris, T. Kent Teague, Robert Dantzer, Jonathan B. Savitz · 2017 · Translational Psychiatry
  35. Inflammation‐induced activation of the indoleamine 2,3‐dioxygenase pathway: Relevance to cancer‐related fatigue
    Sangmi Kim, Brian J. Miller, Michael Edward Stefanek, Andrew H. Miller · 2015 · Cancer
  36. A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder
    Yong‐Ku Kim, Meysam Amidfar, Eunsoo Won · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  37. The strong relationship between bipolar and substance‐use disorder: Mechanisms and treatment implications
    Swann, Alan C. · 2010 · Annals of the New York Academy of Sciences
  38. LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-γ-independent manner by a JNK signaling pathway in primary murine microglia
    Yunxia Wang, Marcus A. Lawson, Robert Dantzer, Keith W. Kelley · 2009 · Brain Behavior and Immunity
  39. Psychiatric and Substance Use Disorders in Individuals with Hepatitis C: Epidemiology and Management
    Loftis, Jennifer M, Matthews, Annette M, Hauser, Peter · 2006 · Drugs
  40. Psychopharmacological Treatment of Depression, Anxiety, Irritability and Insomnia in Patients Receiving Interferon-α: a Prospective Case Series and a Discussion of Biological Mechanisms
    Clementine Maddock, Antonella Baita, M. Germana Orrù, Rossella Sitzia, Alessandra Costa, Elisabetta Muntoni, M. Giulia Farci, Bernardo Carpiniello, Carmine Maria Pariante · 2004 · Journal of Psychopharmacology
  41. Draft for Clinical Practice and Epidemiology in Mental Health Neurobiological Alterations Induced by Exercise and Their Impact on Depressive Disorders
    Ingo Helmich, Alexandra Latini, Andre Sigwalt, Mauro Giovanni Carta, Sergio Machado, Bruna Velasques, Pedro Ribeiro, Henning Budde · 2010 · Clinical Practice and Epidemiology in Mental Health
  42. Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults
    Barbara Strasser, Ken Berger, Dietmar Fuchs · 2014 · European Journal of Nutrition
  43. Mood effects of the amino acids tryptophan and tyrosine
    Gordon Barraclough Parker, Heather Brotchie · 2011 · Acta Psychiatrica Scandinavica
  44. Stress-Related Immune Markers in Depression: Implications for Treatment
    Martina M. Hughes, Thomas J. Connor, Andrew Harkin · 2016 · The International Journal of Neuropsychopharmacology
  45. A global measure of sickness behaviour: Development of the Sickness Questionnaire
    Anna Andréasson, Rikard K. Wicksell, Karin Lodin, Bianka Karshikoff, John Axelsson, Mats Lekander · 2016 · Journal of Health Psychology
  46. Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
    Smith, A K, Simon, J S, Gustafson, E L, Noviello, S, Cubells, J F, Epstein, M P, Devlin, D J, Qiu, P, Albrecht, J K, Brass, C A et al. · 2012 · Molecular Psychiatry
  47. Posttraumatic Stress Disorder: An Immunological Disorder?
    Zhewu Wang, Blaine Caughron, Matthew R. Young · 2017 · Frontiers in Psychiatry
  48. Glia in the cytokine-mediated onset of depression: fine tuning the immune response
    Wendy Karen Jo, Yuanyuan Zhang, Hinderk Meiners Emrich, Detlef E. Dietrich · 2015 · Frontiers in Cellular Neuroscience
  49. Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression
    Michele L. Pucak, Katherine A. L. Carroll, Douglas A. Kerr, Adam L. Kaplin · 2007 · Dialogues in Clinical Neuroscience
  50. IDO and TDO as a potential therapeutic target in different types of depression
    Yanjie Qin, Nanxi Wang, Xinlin Zhang, Xuemei Han, Xuejia Zhai, Yongning Lu · 2018 · Metabolic Brain Disease
  51. Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions
    Fredericks, Carolyn A., Drabant, Emily M., Edge, Michael D., Tillie, Jean M., Hallmayer, Joachim, Ramel, Wiveka, Kuo, Janice R., Mackey, Sean, Gross, James J., Dhabhar, Firdaus S. · 2010 · Brain, Behavior, and Immunity
  52. Tryptophan Metabolism and Immunogenetics in Major Depression: A Role for Interferon-γ Gene
    Myint, Aye Mu, Bondy, Brigitta, Baghai, Thomas C., Eser, Daniela, Nothdurfter, Caroline, Schüle, Cornelius, Zill, Peter, Müller, Norbert, Rupprecht, Rainer, Schwarz, Markus J. · 2013 · Brain, Behavior, and Immunity
  53. The relationship between depressive symptoms and BMI: 2005–2018 NHANES data
    Kaiyin He, Tianying Pang, Hao Huang · 2022 · Journal of Affective Disorders
  54. Depression after Infection with West Nile Virus1
    Kristy O. Murray, Melissa Resnick, Vicki E. Miller · 2007 · Emerging infectious diseases
  55. Serotonin transporters: Implications for antidepressant drug development
    Kellie J. White, Crystal C. Walline, Eric L. Barker · 2005 · The AAPS Journal
  56. Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets
    Ana Dolšak, Stanislav Gobec, Matej Sova · 2020 · Pharmacology & Therapeutics
  57. Neuroinflammation and Depression
    M. Elizabeth Sublette, Teodor T. Postolache · 2012 · Psychosomatic Medicine
  58. Parental support buffers the association of depressive symptoms with cortisol and C-reactive protein during adolescence
    Shu‐Sha Angie Guan, Julienne E. Bower, David M. Almeida, Steve W. Cole, Ronald E. Dahl, Michael R. Irwin, Teresa E. Seeman, Thomas W. McDade, Andrew J. Fuligni · 2016 · Brain Behavior and Immunity
  59. The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
    Knut Asbjørn Hestad, Knut Engedal, Jon Elling Whist, Per G. Farup · 2017 · Frontiers in Psychology
  60. Tryptophan degradation in women with breast cancer: a pilot study
    Debra Lyon, Jeanne M. Walter, Angela Renee Starkweather, Christine M. Schubert, Nancy L. McCain · 2011 · BMC Research Notes
  61. Assessment of Depression in a Rodent Model of Spinal Cord Injury
    Kelsey Luedtke, Sioui Maldonado Bouchard, Sarah A. Woller, Mary Katherine Funk, Miriam Aceves, Michelle A. Hook · 2014 · Journal of Neurotrauma
  62. Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
    Joshua Daniel Rosenblat, Roger S. McIntyre, Gilberto Sousa Alves, Konstantinos Ν. Fountoulakis, Andre Ferrer Carvalho · 2015 · Current Neuropharmacology
  63. Major depression during interferon-α treatment: vulnerability and prevention
    Francis E. Lotrich · 2009 · Dialogues in Clinical Neuroscience
  64. Tryptophan consumption and indoleamines production by peritoneal cavity macrophages
    E Martins, Andrea Cláudia Freitas Ferreira, A L Skorupa, Solange Castro Afeche, José Cipolla‐Neto, L. F. B. P. Costa Rosa · 2004 · Journal of Leukocyte Biology
  65. Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2
    Chelsea Ma, April Wang Armstrong · 2013 · Journal of Dermatological Treatment
  66. Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the Kynurenine Pathway in the mouse hippocampus
    Alexandra K. Brooks, Marcus A. Lawson, Robin A.J. Smith, Tiffany M. Janda, Keith W. Kelley, Robert H. McCusker · 2016 · Journal of Neuroinflammation
  67. The role and mechanism of tryptophan – kynurenine metabolic pathway in depression
    Xiaoli Gong, Rui Chang, Ju Zou, Sijie Tan, Zeyi Huang · 2022 · Reviews in the Neurosciences
  68. The inflammatory underpinning of depression: An historical perspective
    Raz Yirmiya · 2024 · Brain Behavior and Immunity
  69. Animal inflammation-based models of depression and their application to drug discovery
    Li Ma, Konstantin A. Demin, Tatiana O. Kolesnikova, Sergey L. Kharsko, Xiaokang Zhu, Xiaodong Yuan, Cai Song, Дарья Андреевна Мешалкина, Brian E. Leonard, Li Tian et al. · 2017 · Expert Opinion on Drug Discovery
  70. Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders
    Norbert Müller, Markus Schwarz · 2006 · Expert Review of Neurotherapeutics
  71. The possible role of the kynurenine pathway in anhedonia in adolescents
    Vilma Gabbay, Benjamin A. Ely, James S. Babb, Leonard Liebes · 2011 · Journal of Neural Transmission
  72. Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder
    Kuan‐Pin Su, Hsueh‐Chou Lai, Cheng‐Yuan Peng, Wen‐Pang Su, Jane Pei‐Chen Chang, Carmine Maria Pariante · 2019 · Brain Behavior and Immunity
  73. Neuroinflammation and depressive disorder: The role of the hypothalamus
    Alena Černáčková, Zdeňka Ďuračková, Jana Trebatická, Boris Mravec · 2020 · Journal of Clinical Neuroscience
  74. Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: Focus on individual differences
    Anthony Laugeray, Jean‐Marie Launay, Jacques Callebert, Alexandre Surget, Catherine Belzung, Pascal R. Barone · 2010 · Pharmacology Biochemistry and Behavior
  75. The kynurenine pathway in adolescent depression: Preliminary findings from a proton MR spectroscopy study
    Vilma Gabbay, Leonard Liebes, Yisrael Katz, Songtao Liu, Sandra Mendoza, James S. Babb, Rachel G. Klein, Oded Gonen · 2009 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  76. Mind and body: how the health of the body impacts on neuropsychiatry
    Thibault Renoir, Kyoko Hasebe, Laura J. Gray · 2013 · Frontiers in Pharmacology
  77. Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression
    Cato Veen, Aye-Mu Myint, Karin M. Burgerhout, Markus Schwarz, Gregor A. Schütze, Steven A. Kushner, Witte J.G. Hoogendijk, Hemmo A. Drexhage, Veerle Bergink · 2015 · Journal of Affective Disorders
  78. Fish Oil Prevents Lipopolysaccharide-Induced Depressive-Like Behavior by Inhibiting Neuroinflammation
    Shi, Zhe, Ren, Huixia, Huang, Zhijian, Peng, Yu, He, Baixuan, Yao, Xiaoli, Yuan, Ti-Fei, Su, Huanxing · 2017 · Molecular Neurobiology
  79. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats
    David Martín‐Hernández, Hiram Tendilla‐Beltrán, José L. M. Madrigal, Borja García‐Bueno, Juan Carlos Leza, Javier R. Caso · 2018 · Molecular Neurobiology
  80. Plasma free tryptophan revisited: what you need to know and do before measuring it
    A. A-B Badawy · 2008 · Journal of Psychopharmacology
  81. Depressive symptoms following interferon-α therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?
    Kenis, Gunter, Prickaerts, Jos, van Os, Jim, Koek, Ger H., Robaeys, Geert, Steinbusch, Harry W. M., Wichers, Marieke · 2011 · The International Journal of Neuropsychopharmacology
  82. The Link Between Autonomic Nervous System and Rheumatoid Arthritis: From Bench to Bedside
    Francesca Ingegnoli, Massimiliano Buoli, Flavia Antonucci, Lavinia Agra Coletto, Cecilia Maria Esposito, Roberto Felice Caporali · 2020 · Frontiers in Medicine
  83. Interferon-α effects are exaggerated when administered on a psychosocial stressor backdrop: Cytokine, corticosterone and brain monoamine variations
    Hymie Anisman, Michael O. Poulter, Reno Gandhi, Zul Merali, Shawn P. Hayley · 2007 · Journal of Neuroimmunology
  84. The Relationship Between Mental Health, Disease Severity, and Genetic Risk for Depression in Early Rheumatoid Arthritis
    Jack Euesden, Faith Matcham, Matthew H. Hotopf, Sophia E Steer, Andrew Paul Cope, Cathryn M. Lewis, Ian C. Scott · 2017 · Psychosomatic Medicine
  85. The relationship between cytokines and pain/depression: A review and current status
    Thomas B. Strouse · 2007 · Current Pain and Headache Reports
  86. Neuropsychiatric side effects of interferon-alfa therapy.
    Arthur R. Van Gool, Wim H.J. Kruit, G. Stoter, F.K. Engels, Alexander M.M. Eggermont · 2003 · Pharmacy World & Science
  87. Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery
    Caroline M. Forrest, Gillian Mackay, Lynn Oxford, Keith Millar, Lynda Gail Darlington, Michael J. Higgins, Trevor W. Stone · 2011 · Journal of Neurochemistry
  88. Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability
    Sinan Gülöksüz, Marieke Wichers, Günter Kenis, Maurice G. Rüssel, Annick Wauters, Robert M. Verkerk, Baer M.G. Arts, Jim van Os · 2013 · PLoS ONE
  89. Using the affective bias test to predict drug‐induced negative affect: implications for drug safety
    Sarah A. Stuart, Christian M. Wood, Emma S. J. Robinson · 2017 · British Journal of Pharmacology
  90. Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists
    Kyle J. Brymer, Raquel Romay-Tallón, Josh Allen, Héctor J. Caruncho, Lisa E. Kalynchuk · 2019 · Frontiers in Neuroscience
  91. Interferon-α-induced serotonin uptake in Jurkat T cells via mitogen-activated protein kinase and transcriptional regulation of the serotonin transporter
    C.‐W. Tsao, Y-S. Lin, J-T. Cheng, C-F. Lin, Hung‐Tsung Wu, S.‐R. Wu, W-H. Tsai · 2008 · Journal of Psychopharmacology
  92. Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: A 16-week prospective study
    Jennifer M. Loftis, Alexander L. Patterson, Clare Wilhelm, Henry McNett, Benjamin J. Morasco, Marilyn S. Huckans, Timothy R.M. Morgan, Shira Saperstein, Aliya Asghar, Péter Hauser · 2012 · Journal of Psychosomatic Research
  93. Mechanisms of antidepressant action: An integrated dopaminergic perspective
    Stefano Porcelli, Antonio Drago, Chiara Fabbri, Alessandro Serretti · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  94. Central administration of murine interferon-α induces depressive-like behavioral, brain cytokine and neurochemical alterations in mice: A mini-review and original experiments
    Hayley, Shawn, Scharf, Jeff, Anisman, Hymie · 2013 · Brain, Behavior, and Immunity
  95. Neurological and Inflammatory Manifestations in Sjögren’s Syndrome: The Role of the Kynurenine Metabolic Pathway
    Fabíola Reis de Oliveira, Marina Zílio Fantucci, Leidiane Adriano, Valéria Valim, Thiago M. Cunha, Paulo Louzada‐Júnior, Eduardo Melani Rocha · 2018 · International Journal of Molecular Sciences
  96. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis
    M. Markianos, G. Koutsis, M. Evangelopoulos, D. Mandellos, G. Karahalios, C. Sfagos · 2009 · Journal of Neurochemistry
  97. Unkind cytokines: Current evidence for the potential role of cytokines in immune-mediated depression
    Michele L. Pucak, Adam Ian Kaplin · 2005 · International Review of Psychiatry
  98. Are attitudes towards emotions associated with depression? A conceptual and meta-analytic review
    Yoon, Sunkyung, Dang, Van, Mertz, Jessica, Rottenberg, Jonathan · 2018 · Journal of Affective Disorders
  99. The role of glia in late-life depression
    Matthew Paradise, Sharon Linda Naismith, Louisa Margaret Norrie, Manuel B. Graeber, Ian Bernard Hickie · 2012 · International Psychogeriatrics
  100. Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes
    Dávid Kovács, Nóra Eszlári, Péter Petschner, Dorottya Pap, Szilvia Vas, Peter Louis Kovacs, Xénia Gonda, György Bagdy, Gabriella Juhász · 2016 · Journal of Neural Transmission